ID   HACD3_HUMAN             Reviewed;         362 AA.
AC   Q9P035; A0PJA1; B4DRF4; Q280Z3; Q6PD63; Q8IUI5; Q8NC86; Q8NCB1;
AC   Q96T12; Q9NQA7;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   15-JAN-2008, sequence version 2.
DT   15-MAR-2017, entry version 124.
DE   RecName: Full=Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 {ECO:0000305};
DE            EC=4.2.1.134 {ECO:0000269|PubMed:18554506};
DE   AltName: Full=3-hydroxyacyl-CoA dehydratase 3 {ECO:0000303|PubMed:18554506};
DE            Short=HACD3 {ECO:0000303|PubMed:18554506};
DE   AltName: Full=Butyrate-induced protein 1 {ECO:0000303|PubMed:10747961};
DE            Short=B-ind1 {ECO:0000303|PubMed:10747961};
DE            Short=hB-ind1 {ECO:0000303|PubMed:10747961};
DE   AltName: Full=Protein-tyrosine phosphatase-like A domain-containing protein 1 {ECO:0000312|HGNC:HGNC:24175};
GN   Name=HACD3 {ECO:0000303|PubMed:18554506, ECO:0000312|HGNC:HGNC:24175};
GN   Synonyms=BIND1 {ECO:0000303|PubMed:10747961}, PTPLAD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH
RP   RAC1, AND TISSUE SPECIFICITY.
RX   PubMed=10747961; DOI=10.1074/jbc.M000887200;
RA   Courilleau D., Chastre E., Sabbah M., Redeuilh G., Atfi A., Mester J.;
RT   "B-ind1, a novel mediator of Rac1 signaling cloned from sodium
RT   butyrate-treated fibroblasts.";
RL   J. Biol. Chem. 275:17344-17348(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for
RT   300 previously undefined genes expressed in CD34+ hematopoietic
RT   stem/progenitor cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=B-cell, Duodenum, Eye, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29.
RX   PubMed=16516406; DOI=10.1016/j.gene.2006.01.022;
RA   Sabbah M., Saucier C., Redeuilh G.;
RT   "Human B-ind1 gene promoter: cloning and regulation by histone
RT   deacetylase inhibitors.";
RL   Gene 374:128-133(2006).
RN   [7]
RP   INDUCTION BY AKAP12.
RX   PubMed=16638134; DOI=10.1186/1471-2407-6-105;
RA   Liu Y., Gao L., Gelman I.H.;
RT   "SSeCKS/Gravin/AKAP12 attenuates expression of proliferative and
RT   angiogenic genes during suppression of v-Src-induced oncogenesis.";
RL   BMC Cancer 6:105-105(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, CATALYTIC ACTIVITY, PATHWAY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, TISSUE SPECIFICITY, AND INTERACTION
RP   WITH ELOVL FAMILY.
RX   PubMed=18554506; DOI=10.1016/j.febslet.2008.06.007;
RA   Ikeda M., Kanao Y., Yamanaka M., Sakuraba H., Mizutani Y.,
RA   Igarashi Y., Kihara A.;
RT   "Characterization of four mammalian 3-hydroxyacyl-CoA dehydratases
RT   involved in very long-chain fatty acid synthesis.";
RL   FEBS Lett. 582:2435-2440(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-7; SER-114 AND SER-135,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=25687571; DOI=10.1074/mcp.M114.047159;
RA   Boutchueng-Djidjou M., Collard-Simard G., Fortier S., Hebert S.S.,
RA   Kelly I., Landry C.R., Faure R.L.;
RT   "The last enzyme of the de novo purine synthesis pathway 5-
RT   aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP
RT   cyclohydrolase (ATIC) plays a central role in insulin signaling and
RT   the Golgi/endosomes protein network.";
RL   Mol. Cell. Proteomics 14:1079-1092(2015).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Catalyzes the third of the four reactions of the long-
CC       chain fatty acids elongation cycle. This endoplasmic reticulum-
CC       bound enzymatic process, allows the addition of two carbons to the
CC       chain of long- and very long-chain fatty acids/VLCFAs per cycle.
CC       This enzyme catalyzes the dehydration of the 3-hydroxyacyl-CoA
CC       intermediate into trans-2,3-enoyl-CoA, within each cycle of fatty
CC       acid elongation. Thereby, it participates in the production of
CC       VLCFAs of different chain lengths that are involved in multiple
CC       biological processes as precursors of membrane lipids and lipid
CC       mediators. May be involved in Rac1-signaling pathways leading to
CC       the modulation of gene expression. Promotes insulin receptor/INSR
CC       autophosphorylation and is involved in INSR internalization
CC       (PubMed:25687571). {ECO:0000269|PubMed:10747961,
CC       ECO:0000269|PubMed:18554506, ECO:0000269|PubMed:25687571}.
CC   -!- CATALYTIC ACTIVITY: A very-long-chain (3R)-3-hydroxyacyl-CoA = a
CC       very-long-chain trans-2,3-dehydroacyl-CoA + H(2)O.
CC       {ECO:0000269|PubMed:18554506}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=49.5 uM for 3-hydroxypalmitoyl-CoA (at 37 degrees Celsius)
CC         {ECO:0000269|PubMed:18554506};
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis.
CC       {ECO:0000269|PubMed:18554506}.
CC   -!- SUBUNIT: May interact with enzymes of the ELO family (including
CC       ELOVL1); with those enzymes that mediate condensation, the first
CC       of the four steps of the reaction cycle responsible for fatty
CC       acids elongation, may be part of a larger fatty acids elongase
CC       complex (PubMed:18554506). Interacts with RAC1 (PubMed:10747961).
CC       Associates with internalized insulin receptor/INSR complexes on
CC       Golgi/endosomal membranes; HACD3/PTPLAD1 together with ATIC and
CC       PRKAA2/AMPK2 is proposed to be part of a signaling network
CC       regulating INSR autophosphorylation and endocytosis
CC       (PubMed:25687571). {ECO:0000269|PubMed:10747961,
CC       ECO:0000269|PubMed:18554506, ECO:0000269|PubMed:25687571}.
CC   -!- INTERACTION:
CC       Q03463:- (xeno); NbExp=2; IntAct=EBI-359013, EBI-8803426;
CC       Q99IB8:- (xeno); NbExp=2; IntAct=EBI-359013, EBI-6927873;
CC       Q9WMX2:- (xeno); NbExp=3; IntAct=EBI-359013, EBI-6863748;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:18554506}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:18554506}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9P035-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9P035-2; Sequence=VSP_056070;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis, kidney, brain,
CC       liver and weakly in skeletal muscle, spleen and heart. No
CC       expression detected in leukocytes. {ECO:0000269|PubMed:10747961,
CC       ECO:0000269|PubMed:18554506}.
CC   -!- INDUCTION: By AKAP12 and histone deacetylase inhibitors such as
CC       sodium butyrate. {ECO:0000269|PubMed:16638134}.
CC   -!- SIMILARITY: Belongs to the very long-chain fatty acids dehydratase
CC       HACD family. {ECO:0000305}.
CC   -!- CAUTION: Shares some similarity with tyrosine phosphatase proteins
CC       but it has probably no phosphatase activity.
CC       {ECO:0000250|UniProtKB:Q6Y1H2, ECO:0000305|PubMed:18554506}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF29085.1; Type=Frameshift; Positions=356; Evidence={ECO:0000305};
CC       Sequence=BAC11249.1; Type=Frameshift; Positions=359; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ271091; CAB69070.1; -; mRNA.
DR   EMBL; AF161470; AAF29085.1; ALT_FRAME; mRNA.
DR   EMBL; AK027421; BAB55101.1; -; mRNA.
DR   EMBL; AK074857; BAC11249.1; ALT_FRAME; mRNA.
DR   EMBL; AK074898; BAC11277.1; -; mRNA.
DR   EMBL; AK299234; BAG61266.1; -; mRNA.
DR   EMBL; AC011846; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC027220; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC019873; AAH19873.1; -; mRNA.
DR   EMBL; BC035508; AAH35508.1; -; mRNA.
DR   EMBL; BC047685; AAH47685.1; -; mRNA.
DR   EMBL; BC058912; AAH58912.1; -; mRNA.
DR   EMBL; DQ251107; ABB83547.1; -; Genomic_DNA.
DR   CCDS; CCDS45282.1; -. [Q9P035-1]
DR   RefSeq; NP_057479.2; NM_016395.2. [Q9P035-1]
DR   UniGene; Hs.512973; -.
DR   ProteinModelPortal; Q9P035; -.
DR   BioGrid; 119570; 39.
DR   IntAct; Q9P035; 42.
DR   MINT; MINT-1135933; -.
DR   STRING; 9606.ENSP00000261875; -.
DR   SwissLipids; SLP:000000439; -.
DR   iPTMnet; Q9P035; -.
DR   PhosphoSitePlus; Q9P035; -.
DR   SwissPalm; Q9P035; -.
DR   BioMuta; PTPLAD1; -.
DR   DMDM; 166199462; -.
DR   EPD; Q9P035; -.
DR   MaxQB; Q9P035; -.
DR   PaxDb; Q9P035; -.
DR   PeptideAtlas; Q9P035; -.
DR   PRIDE; Q9P035; -.
DR   TopDownProteomics; Q9P035-1; -. [Q9P035-1]
DR   Ensembl; ENST00000261875; ENSP00000261875; ENSG00000074696. [Q9P035-1]
DR   Ensembl; ENST00000442729; ENSP00000392491; ENSG00000074696. [Q9P035-2]
DR   GeneID; 51495; -.
DR   KEGG; hsa:51495; -.
DR   UCSC; uc002apc.4; human. [Q9P035-1]
DR   CTD; 51495; -.
DR   GeneCards; HACD3; -.
DR   H-InvDB; HIX0012353; -.
DR   HGNC; HGNC:24175; HACD3.
DR   HPA; HPA014837; -.
DR   HPA; HPA060347; -.
DR   MIM; 615940; gene.
DR   neXtProt; NX_Q9P035; -.
DR   OpenTargets; ENSG00000074696; -.
DR   PharmGKB; PA142671113; -.
DR   eggNOG; KOG3187; Eukaryota.
DR   eggNOG; COG5198; LUCA.
DR   GeneTree; ENSGT00530000062962; -.
DR   HOGENOM; HOG000008043; -.
DR   HOVERGEN; HBG108301; -.
DR   InParanoid; Q9P035; -.
DR   KO; K10703; -.
DR   PhylomeDB; Q9P035; -.
DR   TreeFam; TF313326; -.
DR   Reactome; R-HSA-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   UniPathway; UPA00094; -.
DR   ChiTaRS; PTPLAD1; human.
DR   GeneWiki; PTPLAD1; -.
DR   GenomeRNAi; 51495; -.
DR   PRO; PR:Q9P035; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000074696; -.
DR   CleanEx; HS_PTPLAD1; -.
DR   ExpressionAtlas; Q9P035; baseline and differential.
DR   Genevisible; Q9P035; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0102344; F:3-hydroxy-behenoyl-CoA dehydratase activity; IEA:UniProtKB-EC.
DR   GO; GO:0102345; F:3-hydroxy-lignoceroyl-CoA dehydratase activity; IEA:UniProtKB-EC.
DR   GO; GO:0018812; F:3-hydroxyacyl-CoA dehydratase activity; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IDA:UniProtKB.
DR   GO; GO:0005096; F:GTPase activator activity; TAS:ProtInc.
DR   GO; GO:0007257; P:activation of JUN kinase activity; TAS:ProtInc.
DR   GO; GO:0030497; P:fatty acid elongation; IDA:UniProtKB.
DR   GO; GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:ProtInc.
DR   GO; GO:0046726; P:positive regulation by virus of viral protein levels in host cell; IMP:AgBase.
DR   GO; GO:0045070; P:positive regulation of viral genome replication; IMP:AgBase.
DR   GO; GO:0016601; P:Rac protein signal transduction; NAS:UniProtKB.
DR   GO; GO:0007266; P:Rho protein signal transduction; IEA:Ensembl.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; TAS:ProtInc.
DR   GO; GO:0042761; P:very long-chain fatty acid biosynthetic process; IDA:UniProtKB.
DR   Gene3D; 2.60.40.790; -; 1.
DR   InterPro; IPR007052; CS_dom.
DR   InterPro; IPR008978; HSP20-like_chaperone.
DR   InterPro; IPR007482; Tyr_Pase-like_PTPLA.
DR   PANTHER; PTHR11035; PTHR11035; 1.
DR   Pfam; PF04387; PTPLA; 1.
DR   SUPFAM; SSF49764; SSF49764; 1.
DR   PROSITE; PS51203; CS; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Coiled coil; Complete proteome;
KW   Endoplasmic reticulum; Fatty acid biosynthesis; Fatty acid metabolism;
KW   Lipid biosynthesis; Lipid metabolism; Lyase; Membrane; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    362       Very-long-chain (3R)-3-hydroxyacyl-CoA
FT                                dehydratase 3.
FT                                /FTId=PRO_0000313724.
FT   TOPO_DOM      1    149       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    150    170       Helical. {ECO:0000255}.
FT   TOPO_DOM    171    185       Lumenal. {ECO:0000255}.
FT   TRANSMEM    186    207       Helical. {ECO:0000255}.
FT   TOPO_DOM    208    217       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    218    235       Helical. {ECO:0000255}.
FT   TOPO_DOM    236    241       Lumenal. {ECO:0000255}.
FT   TRANSMEM    242    256       Helical. {ECO:0000255}.
FT   TOPO_DOM    257    279       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    280    298       Helical. {ECO:0000255}.
FT   TOPO_DOM    299    322       Lumenal. {ECO:0000255}.
FT   TRANSMEM    323    343       Helical. {ECO:0000255}.
FT   TOPO_DOM    344    362       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN        5     94       CS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00547}.
FT   COILED      111    136       {ECO:0000255}.
FT   COMPBIAS    350    353       Poly-Arg.
FT   COMPBIAS    357    360       Poly-Lys.
FT   ACT_SITE    286    286       {ECO:0000250|UniProtKB:P40857}.
FT   ACT_SITE    293    293       {ECO:0000250|UniProtKB:P40857}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:25944712}.
FT   MOD_RES       7      7       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     114    114       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     135    135       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      69    123       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056070.
FT   VARIANT      56     56       E -> K (in dbSNP:rs11632737).
FT                                /FTId=VAR_037712.
FT   VARIANT     269    269       M -> L (in dbSNP:rs2279854).
FT                                /FTId=VAR_037713.
FT   CONFLICT     60     60       E -> K (in Ref. 3; BAB55101).
FT                                {ECO:0000305}.
FT   CONFLICT    245    245       F -> I (in Ref. 3; BAC11277).
FT                                {ECO:0000305}.
FT   CONFLICT    282    282       W -> G (in Ref. 5; AAH35508).
FT                                {ECO:0000305}.
FT   CONFLICT    292    292       A -> V (in Ref. 2; AAF29085).
FT                                {ECO:0000305}.
FT   CONFLICT    352    362       RRYGQKKKKIH -> LKMRAGAVAHACDPSALGG (in
FT                                Ref. 1; CAB69070). {ECO:0000305}.
FT   CONFLICT    361    361       I -> K (in Ref. 5; AAH35508).
FT                                {ECO:0000305}.
SQ   SEQUENCE   362 AA;  43160 MW;  1B3591E88DD85D16 CRC64;
     MENQVLTPHV YWAQRHRELY LRVELSDVQN PAISITENVL HFKAQGHGAK GDNVYEFHLE
     FLDLVKPEPV YKLTQRQVNI TVQKKVSQWW ERLTKQEKRP LFLAPDFDRW LDESDAEMEL
     RAKEEERLNK LRLESEGSPE TLTNLRKGYL FMYNLVQFLG FSWIFVNLTV RFCILGKESF
     YDTFHTVADM MYFCQMLAVV ETINAAIGVT TSPVLPSLIQ LLGRNFILFI IFGTMEEMQN
     KAVVFFVFYL WSAIEIFRYS FYMLTCIDMD WKVLTWLRYT LWIPLYPLGC LAEAVSVIQS
     IPIFNETGRF SFTLPYPVKI KVRFSFFLQI YLIMIFLGLY INFRHLYKQR RRRYGQKKKK
     IH
//
